RPRX - Royalty Pharma Plc - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RPRX is currently covered by 4 analysts with an average price target of $58. This is a potential upside of $11.31 (24.22%) from yesterday's end of day stock price of $46.69.

Royalty Pharma Plc's activity chart (see below) currently has 82 price targets and 61 ratings on display. The stock rating distribution of RPRX is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.45% with an average time for these price targets to be met of 303.2 days.

Highest price target for RPRX is $56, Lowest price target is $38, average price target is $46.5.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 27-Jan-2026.

Currently out of the existing stock ratings of RPRX, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Jul-2020

$50

$4.59 (10.11%)

$48

1 months 12 days ago
(27-Jan-2026)

3/8 (37.5%)

$9.26 (22.73%)

330

Buy Since 06-Apr-2022

$56

$10.59 (23.32%)

$54

4 months 5 days ago
(06-Nov-2025)

3/22 (13.64%)

$15.22 (37.32%)

534

Hold Since 03-Jun-2024

$38

$-7.41 (-16.32%)

$28

5 months 23 days ago
(16-Sep-2025)

5/6 (83.33%)

$2.78 (7.89%)

661

Buy Since 13-Jul-2020

$42

$-3.41 (-7.51%)

$42

5 months 27 days ago
(12-Sep-2025)

3/4 (75%)

$5.84 (16.15%)

418

Buy Since 29-Oct-2021

$40

$-5.41 (-11.91%)

$60

1 years 4 months 14 days ago
(25-Oct-2024)

1/4 (25%)

$13.93 (53.43%)

376

Show more analysts

Please expand the browser size to see the chart

What is RPRX (Royalty Pharma Plc) average time for price targets to be met?

On average it took 303.2 days on average for the stock forecasts to be realized with a an average price target met ratio 25.45

Which analyst has the current highest performing score on RPRX (Royalty Pharma Plc) with a proven track record?

TERENCE FLYNN

Which analyst has the most public recommendations on RPRX (Royalty Pharma Plc)?

Terence Flynn works at MORGAN STANLEY and has 3 price targets and 7 ratings on RPRX

Which analyst is the currently most bullish on RPRX (Royalty Pharma Plc)?

Ivan Feinseth with highest potential upside - $11.59

Which analyst is the currently most reserved on RPRX (Royalty Pharma Plc)?

Ashwani Verma with lowest potential downside - -$7.41

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?